Clover Health Investments, Corp. /De financial data

Symbol
CLOV on Nasdaq
Location
30 Montgomery Street, Jersey City, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Social Capital Hedosophia Holdings Corp. III (to 1/7/2021)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 160 % +28%
Debt-to-equity 293 % +26.2%
Return On Equity -13.2 % +80.4%
Return On Assets -6.67 % +78.9%
Operating Margin -3.34 % +79.5%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 610M USD +69.4%
Weighted Average Number of Shares Outstanding, Basic 490M shares +1.63%
Weighted Average Number of Shares Outstanding, Diluted 490M shares +1.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.37B USD +8.77%
General and Administrative Expense 176M USD -3.61%
Operating Income (Loss) -45.7M USD +77.7%
Net Income (Loss) Attributable to Parent -43M USD +79.8%
Earnings Per Share, Basic -0.44 USD/shares +38%
Earnings Per Share, Diluted -0.44 USD/shares +38%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 195M USD +58.3%
Other Assets, Current 15.6M USD -16.2%
Assets, Current 343M USD -19.8%
Property, Plant and Equipment, Net 5.31M USD +4.43%
Operating Lease, Right-of-Use Asset 2.59M USD -28.6%
Goodwill 0 USD -100%
Other Assets, Noncurrent 13.3M USD -2.71%
Assets 581M USD +1.77%
Contract with Customer, Liability, Current 17K USD -100%
Liabilities, Current 214M USD -18.2%
Operating Lease, Liability, Noncurrent 2.32M USD -29.5%
Other Liabilities, Noncurrent 26.1M USD +12.6%
Liabilities 240M USD -15.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.58M USD +33.2%
Retained Earnings (Accumulated Deficit) -2.2B USD -1.99%
Stockholders' Equity Attributable to Parent 323M USD -34%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 341M USD +19.1%
Liabilities and Equity 581M USD +1.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 25.9M USD -67.2%
Net Cash Provided by (Used in) Financing Activities -3.36M USD -57.4%
Net Cash Provided by (Used in) Investing Activities 9.19M USD -9.78%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 31.8M USD -63.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 195M USD +10.2%
Deferred Tax Assets, Valuation Allowance 401M USD +0.98%
Deferred Tax Assets, Gross 403M USD +1.14%
Operating Lease, Liability 3.33M USD -28.7%
Payments to Acquire Property, Plant, and Equipment 445K USD +77.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -42.2M USD +79.5%
Lessee, Operating Lease, Liability, to be Paid 3.91M USD -30.8%
Property, Plant and Equipment, Gross 11.2M USD +16.1%
Operating Lease, Liability, Current 1.35M USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.16M USD -8.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.26M USD -27.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 581K USD -41.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.19M USD +3.03%
Deferred Tax Assets, Operating Loss Carryforwards 320M USD -0.15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 303K USD -74.5%
Additional Paid in Capital 2.58B USD +4.68%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 2.27M USD +38.8%
Share-based Payment Arrangement, Expense 141M USD -14.2%
Interest Expense 7K USD -99.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%